CDKN2A and nasopharyngeal carcinoma: Overexpression of cyclin D1, as well as the presence of a p16-resistant form of CDK4 (CDK4R24C) and loss of p16/CDKN2A, suppress cellular differentiation, which has implications concerning its association with EBV infection in undifferentiated NPC.